Global Systemic Psoriasis Therapeutics Market 2016-2020
About the Systemic Psoriasis Therapeutics Market
Psoriasis is a commonly diagnosed immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes a build-up of red, thick white, or silvery patches. It modifies the normal cell cycle of the skin such that new cells move to the surface of the skin quickly to form patches called plaques. These plaques are commonly found on the knees, elbows, scalp, hand and feet. The condition mostly occurs among adults (18 years-35 years), but can also be seen in adolescents (12 years-18 years) and children (under 10 years).
Psoriasis is more prevalent among Caucasians compared to African-Americans. According to a World Health Organization (WHO) document of 2015, the global prevalence of psoriasis is approximately 2%-3%. However, it is approximately 4.6% in developed countries. In addition, the risk of an individual getting diagnosed with psoriasis is 41% if both parents have psoriasis, 14% in case one parent is affected, and 6% if a sibling has psoriasis.
Technavio’s analysts forecast the global systemic psoriasis therapeutics market to grow at a CAGR of 9.41% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global systemic psoriasis therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the from the sales of branded, generic, and off-label drugs used to treat psoriasis. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Systemic Psoriasis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Johnson & Johnson
• Celgene
• Amgen
• Pfizer
Other prominent vendors
• AbGenomics
• Almirall
• Anacor Pharmaceuticals
• ApoPharma
• Astellas Pharma
• AstraZeneca
• Aurinia Pharmaceuticals
• Biocon
• Biogen Idec
• Biotest
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Can-Fite BioPharma
• Cellceutix Corporation
• Coherus Biosciences
• Creabilis
• Crescendo Biologics
• Delenex Therapeutics
• Dermira
• Eli Lilly
• F. Hoffmann-La Roche
• Forward Pharma
• G & W Laboratories
• GlaxoSmithKline
• Idera Pharmaceuticals
• Incyte
• Kadmon
• kinetabio
• KPI Therapeutics
• Kyowa Hakko Kirin
• LEO Pharma
• Maruho
• Merck
• Mitsubishi Tanabe Pharma
• Moleculin
• MorphoSys
• Novartis
• Prism Pharma
• Promius Pharma
• Prothena Biosciences
• Provectus Biopharmaceuticals
• Sandoz
• Sun Pharmaceuticals
• Takeda Pharmaceuticals
• Taro Pharmaceuticals
• TFS
• UCB
• Valeant Pharmaceuticals
• VBL Therapeutics
• XenoPort
• Ziarco Pharma
Market driver
• Dominance of market by biologics
• For a full, detailed list, view our report
Market challenge
• Physician's reluctance to prescribe biosimilars
• For a full, detailed list, view our report
Market trend
• Advent of biologics with novel MOA and cell-based strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Psoriasis is a commonly diagnosed immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes a build-up of red, thick white, or silvery patches. It modifies the normal cell cycle of the skin such that new cells move to the surface of the skin quickly to form patches called plaques. These plaques are commonly found on the knees, elbows, scalp, hand and feet. The condition mostly occurs among adults (18 years-35 years), but can also be seen in adolescents (12 years-18 years) and children (under 10 years).
Psoriasis is more prevalent among Caucasians compared to African-Americans. According to a World Health Organization (WHO) document of 2015, the global prevalence of psoriasis is approximately 2%-3%. However, it is approximately 4.6% in developed countries. In addition, the risk of an individual getting diagnosed with psoriasis is 41% if both parents have psoriasis, 14% in case one parent is affected, and 6% if a sibling has psoriasis.
Technavio’s analysts forecast the global systemic psoriasis therapeutics market to grow at a CAGR of 9.41% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global systemic psoriasis therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the from the sales of branded, generic, and off-label drugs used to treat psoriasis. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Systemic Psoriasis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Johnson & Johnson
• Celgene
• Amgen
• Pfizer
Other prominent vendors
• AbGenomics
• Almirall
• Anacor Pharmaceuticals
• ApoPharma
• Astellas Pharma
• AstraZeneca
• Aurinia Pharmaceuticals
• Biocon
• Biogen Idec
• Biotest
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Can-Fite BioPharma
• Cellceutix Corporation
• Coherus Biosciences
• Creabilis
• Crescendo Biologics
• Delenex Therapeutics
• Dermira
• Eli Lilly
• F. Hoffmann-La Roche
• Forward Pharma
• G & W Laboratories
• GlaxoSmithKline
• Idera Pharmaceuticals
• Incyte
• Kadmon
• kinetabio
• KPI Therapeutics
• Kyowa Hakko Kirin
• LEO Pharma
• Maruho
• Merck
• Mitsubishi Tanabe Pharma
• Moleculin
• MorphoSys
• Novartis
• Prism Pharma
• Promius Pharma
• Prothena Biosciences
• Provectus Biopharmaceuticals
• Sandoz
• Sun Pharmaceuticals
• Takeda Pharmaceuticals
• Taro Pharmaceuticals
• TFS
• UCB
• Valeant Pharmaceuticals
• VBL Therapeutics
• XenoPort
• Ziarco Pharma
Market driver
• Dominance of market by biologics
• For a full, detailed list, view our report
Market challenge
• Physician's reluctance to prescribe biosimilars
• For a full, detailed list, view our report
Market trend
• Advent of biologics with novel MOA and cell-based strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
